NCIt definition : A receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic
activities. Upon administration, anlotininib targets multiple RTKs, including vascular
endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent
may both inhibit angiogenesis and halt tumor cell growth.;
UNII : GKF8S4C432;
InChIKey : KSMZEXLVHXZPEF-UHFFFAOYSA-N;
CAS number : 1058156-90-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1058156-90-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;